-
1
-
-
13844271913
-
Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound
-
L.B. Feril Jr. T. Kondo Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound J. Radiat. Res. 45 2004 479 489
-
(2004)
J. Radiat. Res.
, vol.45
, pp. 479-489
-
-
Feril, L.B.1
Kondo, T.2
-
3
-
-
0020027749
-
First clinical experience with extracorporeally induced destruction of kidney stones by shock waves
-
C. Chaussy E. Schmiedt D. Jocham W. Brendel B. Forssmann V. Walther First clinical experience with extracorporeally induced destruction of kidney stones by shock waves J. Urol. 127 1982 417 420
-
(1982)
J. Urol.
, vol.127
, pp. 417-420
-
-
Chaussy, C.1
Schmiedt, E.2
Jocham, D.3
Brendel, W.4
Forssmann, B.5
Walther, V.6
-
4
-
-
0036288286
-
Update on shock wave lithotripsy technology
-
B.K. Auge G.M. Preminger Update on shock wave lithotripsy technology Curr. Opin. Urol. 12 2002 287 290
-
(2002)
Curr. Opin. Urol.
, vol.12
, pp. 287-290
-
-
Auge, B.K.1
Preminger, G.M.2
-
5
-
-
1242319244
-
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience
-
A. Blana B. Walter S. Rogenhofer W.F. Wieland High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience Urology 63 2004 297 300
-
(2004)
Urology
, vol.63
, pp. 297-300
-
-
Blana, A.1
Walter, B.2
Rogenhofer, S.3
Wieland, W.F.4
-
7
-
-
0026661474
-
Free radical formation induced by ultrasound and its biological implications
-
P. Riesz T. Kondo Free radical formation induced by ultrasound and its biological implications Free Radic. Biol. Med. 13 1992 247 270
-
(1992)
Free Radic. Biol. Med.
, vol.13
, pp. 247-270
-
-
Riesz, P.1
Kondo, T.2
-
9
-
-
0034652580
-
Apoptosis induction of human myeloid leukemic cells by ultrasound exposure
-
H. Ashush L.A. Rozenszajn M. Blass M. Barda-Saad D. Azimov J. Radnay D. Zipori U. Rosenschein Apoptosis induction of human myeloid leukemic cells by ultrasound exposure Cancer Res. 60 2000 1014 1020
-
(2000)
Cancer Res.
, vol.60
, pp. 1014-1020
-
-
Ashush, H.1
Rozenszajn, L.A.2
Blass, M.3
Barda-Saad, M.4
Azimov, D.5
Radnay, J.6
Zipori, D.7
Rosenschein, U.8
-
10
-
-
4043109216
-
Sonodynamic therapy – a review of the synergistic effect of drugs and ultrasound
-
I. Rosenthal J.Z. Sostaric P. Riesz Sonodynamic therapy – a review of the synergistic effect of drugs and ultrasound Ultrason. Sonochem. 11 2004 349 363
-
(2004)
Ultrason. Sonochem.
, vol.11
, pp. 349-363
-
-
Rosenthal, I.1
Sostaric, J.Z.2
Riesz, P.3
-
13
-
-
0026658014
-
Ultrasound-enhanced effects of adriamycin against murine tumors
-
A.H. Saad G.M. Hahn Ultrasound-enhanced effects of adriamycin against murine tumors Ultrasound Med. Biol. 18 1992 715 723
-
(1992)
Ultrasound Med. Biol.
, vol.18
, pp. 715-723
-
-
Saad, A.H.1
Hahn, G.M.2
-
14
-
-
0030057628
-
In vitro action of continuous-wave ultrasound combined with adriamycin. X rays or hyperthermia
-
G.H. Harrison E.K. Balcer-Kubiczek P.L. Gutierrez In vitro action of continuous-wave ultrasound combined with adriamycin. X rays or hyperthermia Radiat. Res. 145 1996 98 101
-
(1996)
Radiat. Res.
, vol.145
, pp. 98-101
-
-
Harrison, G.H.1
Balcer-Kubiczek, E.K.2
Gutierrez, P.L.3
-
16
-
-
0036326944
-
Effects of dissolved gasses and echo contrast agent on ultrasound mediated in vitro gene transfection
-
R. Ogawa T. Kondo H. Honda Q.L. Zhao S. Fukuda P. Riesz Effects of dissolved gasses and echo contrast agent on ultrasound mediated in vitro gene transfection Ultrason. Sonochem. 9 2002 197 203
-
(2002)
Ultrason. Sonochem.
, vol.9
, pp. 197-203
-
-
Ogawa, R.1
Kondo, T.2
Honda, H.3
Zhao, Q.L.4
Fukuda, S.5
Riesz, P.6
-
19
-
-
0028057250
-
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
-
M.E. Reff K. Carner K.S. Chambers P.C. Chinn J.E. Leonard R. Raab R.A. Newman N. Hanna D.R. Anderson Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood 83 1994 435 445
-
(1994)
Blood
, vol.83
, pp. 435-445
-
-
Reff, M.E.1
Carner, K.2
Chambers, K.S.3
Chinn, P.C.4
Leonard, J.E.5
Raab, R.6
Newman, R.A.7
Hanna, N.8
Anderson, D.R.9
-
21
-
-
0031693706
-
Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody
-
H. Taji Y. Kagami Y. Okada M. Andou Y. Nishi H. Saito M. Seto Y. Morishima Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody Jpn. J. Cancer Res. 89 1998 748 756
-
(1998)
Jpn. J. Cancer Res.
, vol.89
, pp. 748-756
-
-
Taji, H.1
Kagami, Y.2
Okada, Y.3
Andou, M.4
Nishi, Y.5
Saito, H.6
Seto, M.7
Morishima, Y.8
-
22
-
-
0345337254
-
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
-
P. McLaughlin A.J. Grillo-López B.K. Link R. Levy M.S. Czuczman M.E. Williams M.R. Heyman I. Bence-Bruckler C.A. White F. Cabanillas V. Jain A.D. Ho J. Lister K. Wey D. Shen B.K. Dallaire Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J. Clin. Oncol. 16 1998 2825 2833
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 2825-2833
-
-
McLaughlin, P.1
Grillo-López, A.J.2
Link, B.K.3
Levy, R.4
Czuczman, M.S.5
Williams, M.E.6
Heyman, M.R.7
Bence-Bruckler, I.8
White, C.A.9
Cabanillas, F.10
Jain, V.11
Ho, A.D.12
Lister, J.13
Wey, K.14
Shen, D.15
Dallaire, B.K.16
-
23
-
-
0034657295
-
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma
-
J.D. Hainsworth H.A. Burris III L.H. Morrissey S. Litchy D.C. Scullin Jr. J.D. Bearden III P. Richards F.A. Greco Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma Blood 95 2000 3052 3056
-
(2000)
Blood
, vol.95
, pp. 3052-3056
-
-
Hainsworth, J.D.1
Burris, H.A.2
Morrissey, L.H.3
Litchy, S.4
Scullin, D.C.5
Bearden, J.D.6
Richards, P.7
Greco, F.A.8
-
24
-
-
0033067232
-
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin’s lymphoma: results of a phase II trial of rituximab
-
T.A. Davis C.A. White A.J. Grillo-López W.S. Velásquez B. Link D.G. Maloney R.O. Dillman M.E. Williams A. Mohrbacher R. Weaver S. Dowden R. Levy Single-agent monoclonal antibody efficacy in bulky non-Hodgkin’s lymphoma: results of a phase II trial of rituximab J. Clin. Oncol. 17 1999 1851 1857
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 1851-1857
-
-
Davis, T.A.1
White, C.A.2
Grillo-López, A.J.3
Velásquez, W.S.4
Link, B.5
Maloney, D.G.6
Dillman, R.O.7
Williams, M.E.8
Mohrbacher, A.9
Weaver, R.10
Dowden, S.11
Levy, R.12
-
25
-
-
0033855660
-
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin’s lymphoma: safety and efficacy of re-treatment
-
T.A. Davis A.J. Grillo-López C.A. White P. McLaughlin M.S. Czuczman B.K. Link D.G. Maloney R.L. Weaver J. Rosenberg R. Levy Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin’s lymphoma: safety and efficacy of re-treatment J. Clin. Oncol. 18 2000 3135 3143
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 3135-3143
-
-
Davis, T.A.1
Grillo-López, A.J.2
White, C.A.3
McLaughlin, P.4
Czuczman, M.S.5
Link, B.K.6
Maloney, D.G.7
Weaver, R.L.8
Rosenberg, J.9
Levy, R.10
-
26
-
-
0032530342
-
Rituximab(anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study
-
B. Coiffier C. Haioun N. Ketterer A. Engert H. Tilly D. Ma P. Johnson A. Lister M. Feuring-Buske J.A. Radford R. Capdeville V. Diehl F. Reyes Rituximab(anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study Blood 92 1998 1927 1932
-
(1998)
Blood
, vol.92
, pp. 1927-1932
-
-
Coiffier, B.1
Haioun, C.2
Ketterer, N.3
Engert, A.4
Tilly, H.5
Ma, D.6
Johnson, P.7
Lister, A.8
Feuring-Buske, M.9
Radford, J.A.10
Capdeville, R.11
Diehl, V.12
Reyes, F.13
-
27
-
-
2642510885
-
Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma
-
K. Tobinai T. Igarashi K. Itoh Y. Koboyashi M. Taniwaki M. Ogura T. Kinoshita T. Hotta K. Aikawa K. Tsushita A. Hiraoka Y. Matsuno S. Nakamura S. Mori Y. Ohashi Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma Ann. Oncol. 15 2004 821 830
-
(2004)
Ann. Oncol.
, vol.15
, pp. 821-830
-
-
Tobinai, K.1
Igarashi, T.2
Itoh, K.3
Koboyashi, Y.4
Taniwaki, M.5
Ogura, M.6
Kinoshita, T.7
Hotta, T.8
Aikawa, K.9
Tsushita, K.10
Hiraoka, A.11
Matsuno, Y.12
Nakamura, S.13
Mori, S.14
Ohashi, Y.15
-
28
-
-
0026508561
-
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
-
V.A. Fadok D.R. Voelker P.A. Campbell J.J. Cohen D.L. Bratton P.M. Henson Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J. Immunol. 148 1992 2207 2216
-
(1992)
J. Immunol.
, vol.148
, pp. 2207-2216
-
-
Fadok, V.A.1
Voelker, D.R.2
Campbell, P.A.3
Cohen, J.J.4
Bratton, D.L.5
Henson, P.M.6
-
30
-
-
0029043888
-
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V
-
I. Vermes C. Haanen H. Steffens-Nakken C. Reutelingsperger A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V J. Immunol. Methods 184 1995 39 51
-
(1995)
J. Immunol. Methods
, vol.184
, pp. 39-51
-
-
Vermes, I.1
Haanen, C.2
Steffens-Nakken, H.3
Reutelingsperger, C.4
-
32
-
-
0037350573
-
Dose-dependent inhibition of ultrasound-induced cell killing and free radical production by carbon dioxide
-
L.B. Feril Jr. T. Kondo R. Ogawa Q.L. Zhao Dose-dependent inhibition of ultrasound-induced cell killing and free radical production by carbon dioxide Ultrason. Sonochem. 10 2003 81 84
-
(2003)
Ultrason. Sonochem.
, vol.10
, pp. 81-84
-
-
Feril, L.B.1
Kondo, T.2
Ogawa, R.3
Zhao, Q.L.4
-
33
-
-
0036085574
-
Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway
-
H. Honda Q.L. Zhao T. Kondo Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway Ultrasound Med. Biol. 28 2002 673 682
-
(2002)
Ultrasound Med. Biol.
, vol.28
, pp. 673-682
-
-
Honda, H.1
Zhao, Q.L.2
Kondo, T.3
|